Stockreport

Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF This collaboration addresses a critical gap in care that disproportionately affects women, who are at a 47% higher risk of developing statin intolerance compared to men [Read more]